Redding, California, Aug. 02, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘3D Cell Culture Market by Product (Low Attachment Surfaces, Hanging Drop Method, Hydrogel, Porous Scaffold, Fibrous Scaffold), Application (Cancer Research, Regenerative Medicine, Tissue Engineering, Drug Discovery), and End User - Global Forecast to 2030,’ published by Meticulous Research®, the 3D Cell Culture market is projected to reach $4.02 billion by 2030, at a CAGR of 15.1% from 2023 to 2030.
3D cell culture is frequently employed in research that requires in vivo model systems to test the impact of a foreign substance on physiological organs or tissues since they can closely mimic the structure and microscopic structure of organs. While 2D cultures have long been used as the standard for investigating disease and cellular mechanisms due to their low cost and ease of use, 3D cell cultures have grown in popularity over the last decade due to their physiological importance and accuracy in replicating the complicated architecture of tissues.
Download Free Report Sample Now: https://www.meticulousresearch.com/download-sample-report/cp_id=1246
The growth of this market is driven by increasing cancer research, the growing use of 3D cell culture in drug discovery and toxicology testing, high demand for organ transplants, rising investments and funding for life science research, and the utilization of 3D cell culture models in animal testing. Additionally, emerging economies and a growing focus on regenerative medicine are expected to offer significant market growth opportunities.
Increasing Need for Liver and Other Organ Transplants to Boost the Growth of the 3D Cell Culture Market
Over the past decade, there has been a significant increase in the demand for liver and other organ transplants. This growth in demand can be attributed to factors such as the rising incidence of organ failure, the high success rate of transplant procedures, and improved post-transplant outcomes. Metabolic diseases, including diabetes, high blood pressure, heart disease, and metabolic syndrome, are the primary causes of organ failure. The prevalence of these diseases has contributed to a higher number of organ transplant cases.
According to the Health Resources and Services Administration (HRSA), in 2022, 1 million organs were transplanted worldwide, out of which 104,234 women, men, and children were on the waiting list. Liver transplantation is necessary when the liver fails due to various reasons, including alcoholic liver disease, hepatitis, metabolic diseases, and other liver diseases. According to GLOBOCAN, there were 905,677 cases of liver cancer detected in 2020. This number is projected to increase to 1.2 million by 2030. The rising incidence of liver cancer underscores the need for liver transplantation. 3D cell culture improves or aids in primary hepatic functions such as drug-metabolizing protein activation of various liver cells, allowing for long-term and repeated-dose toxicity studies.
The 3D Cell Culture market is segmented based on Product [Scaffold-free platforms (Low Attachment Surfaces, Hanging Drop Method), Scaffold-based platforms (Hydrogels, Porous Scaffolds, Fibrous Scaffolds, Other Scaffold based platforms), Accessories and Consumables, and Other Products], Application [Cancer Research, Regenerative
Medicines, Drug Discovery and Testing, Tissue Engineering, Other Applications], End User [Pharmaceutical and Biotechnology Companies, Academic and Research Institutes], and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.
Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=1246
The report also includes an extensive assessment of the key growth strategies adopted by leading market players in the last three to four years. Some of the key players operating in the 3D cell culture market are Thermo Fisher Scientific (U.S.), Merck KGaA (Germany), Lonza Group AG (Switzerland), Corning Incorporated (U.S.), UPM-Kymmene Corporation (Finland), REPROCELL Inc. (Japan), SYNTHECON, INCORPORATED (South Africa), InSphero AG (Switzerland), Advanced BioMatrix (U.S.), MIMETAS B.V. (Netherlands), and Greiner Bio-One International GmbH (Austria).
Among the products, in 2023, the scaffold-based platforms segment is expected to account for the largest share of the 3D cell culture market. Scaffold-based platforms replicate tissue-specific extracellular matrix (ECM) composition, enabling the study of cell-ECM interactions and identifying patient-specific responses to anti-cancer drugs. The numerous advantages scaffold-based platforms offer make them a preferred choice for conducting 3D cell cultures.
Among the applications, in 2023, the cancer research segment is expected to account for the largest share of the 3D cell culture market. The large market share of this segment can be attributed to the increased funding for cancer research to develop novel treatments and therapies. For instance, in September 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) announced funding of $49 million for cancer research and product development. Furthermore, the high prevalence of cancer and the benefits offered by 3D cell culture in cancer research are key factors contributing to the significant market share of this segment.
Quick Buy – 3D Cell Culture Market- Global Opportunity Analysis and Industry Forecast (2023-2030), Research Report:
Among the end users, in 2023, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the 3D cell culture market. The large market share of this segment can be attributed to the substantial investments in R&D made by pharmaceutical and biotechnology companies to introduce innovative therapies and treatments. According to the Global Research and Development Expenditures data, in 2020, global R&D expenditure reached USD 2.52 trillion, highlighting the significant investment in this field.
Based on geography, the global 3D cell culture market is segmented into North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (Japan, China, India, Australia, Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the global 3D cell culture market. North America’s major market share can be attributed to the rapid adoption of 3D cell culture systems in various cancer research studies, advanced research infrastructure, and availability of funding for life science research.
Furthermore, in 2023, the U.S. is expected to be the largest market shareholder in North America. North America’s major market share is attributed to the highly developed healthcare infrastructure and the presence of major market players such as Thermo Fisher Scientific (U.S.), Merck KGaA (Germany), and Lonza Group AG (Switzerland).
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/3d-cell-culture-market-1246
Scope of the Report:
3D Cell Culture Market Size & Trend Analysis - by Product
- Scaffold-free platforms
- Low Attachment Surfaces
- Hanging Drop Method
- Scaffold-based platforms
- Hydrogels
- Porous Scaffolds
- Fibrous Scaffolds
- Other Scaffold-based platforms
- Accessories and Consumables
- Other Products
Notes: 1. Other scaffold-based platforms include solid scaffolds and non-gel polymer scaffolds)
2. Other products include bioreactors & microchips)
3D Cell Culture Market Size & Trend Analysis - by Application
- Cancer Research
- Regenerative Medicines
- Drug Discovery and Testing
- Tissue Engineering
- Other Applications
Note: Other applications include toxicology and disease modeling.
3D Cell Culture Market Size & Trend Analysis - by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
3D Cell Culture Market Size & Trend Analysis - by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Italy
- U.K.
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Request Free Report Sample Now: https://www.meticulousresearch.com/request-sample-report/cp_id=1246
Related Reports:
Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, academic) - Global Forecast to 2029
https://www.meticulousresearch.com/product/cell-culture-market-4788
Cell Culture Reagents Market by Product (Growth Factors and Cytokines, Supplement, Cryoprotective, Antibiotic, Buffer), Application (Bioproduction (Antibody, Protein, Vaccine), Research, Diagnostics), End User (Pharma, Academic) - Global Forecast to 2029
https://www.meticulousresearch.com/product/cell-culture-reagents-market-5322
Cell Culture Media Market by Product (Serum-free, Chemically Defined, Classical, Xeno-free/Animal Component Free), Application (Monoclonal Antibody, Diagnostics, Cancer and Stem Cell Research), End User (Pharma & Biotech, Academic)- Global Forecast to 2029
https://www.meticulousresearch.com/product/cell-culture-media-market-5318
Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Media, Disposables, Centrifuge, Filtration System), Cell Type (Human, Animal), Technology (Filtration, Surface Marker), Application (Research, Therapeutics), End User- Global Forecast to 2024
https://www.meticulousresearch.com/product/Cell-Isolation-Cell-Separation-Market-4966
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/797/3d-cell-culture-market-2030
